28 Nov 2024 | News
Technophage congratulates INFARMED, I.P. on the approval of phage therapy in Portugal, a groundbreaking achievement celebrated alongside the release of the “Guiding Standard on the Use of Compounded Medications for Phage Therapy in the Hospital Context – Magistral...
6 Nov 2024 | News
We are thrilled to announce that Technophage has once again been recognized by IAPMEI, I.P. – Agência para a Competitividade e Inovação (Agency for Competitiveness and Innovation) with the prestigious ‘PME Líder’ distinction for 2024! Receiving this honor for another...
22 Jul 2024 | News
Technophage has been featured in the recent article “The 7 Biotech Companies in Portugal You Should Know About in 2024” by Labiotech! This recognition is a validation to our team’s hard work, dedication, and innovative spirit in advancing...
5 Jul 2024 | News
We are thrilled to announce that Technophage was selected by Innovate UK as one of the 19 most promising solutions globally in the fight against antibiotic resistance! Technophae’s CEO and CSO participated in the Inward AMR Innovation Mission UK 2024, that took...
5 Jul 2024 | News
Recently, Technophage CEO Miguel Garcia, attended the prestigious JLABS EMEA CEO Summit 2024. This event, held in the exciting city of London, brought together leaders from the biotech and life sciences industries. It is an incredible platform for collaboration,...
25 Jun 2024 | News
Technophage is proud to announce that it has recently been granted with the ‘COTEC Innovative Status 2024’. COTEC Portugal is the main Portuguese business association for the promotion of business innovation and technological cooperation. The COTEC Innovative Status...
